Vox Markets Logo

Microsaic Systems inks commercial deal with Axcend Corp

10:35, 26th February 2020
Francesca Morgan
Company News
TwitterFacebookLinkedIn

Microsaic Systems (AIM:MSYS), the developer of mass spectrometry instruments, has signed a global collaboration and commercialisation agreement with liquid chromatography provider, Axcend Corp.

The agreement will see the integration of the Microsaic 4500 MiD®, a compact MS detector, with the portable Axcend Focus LC®, a small footprint liquid chromatography system, to form the ‘LC/MS system.’

The companies will work together to commercialise the combined product globally using both groups’ direct sales and selected distribution channels.

Microsaic has a direct sales presence in the UK and across certain European markets whilst Axcend has a direct presence in North America.

"We are particularly excited by this partnership, which combines two highly differentiated compact products into a very powerful LC/MS system,” said Glenn Tracey, Chief Executive of Microsaic.

Shares in Microsaic Systems were trading 5.56% higher at 0.95p during Wednesday trading.

MSYS price chart

"Many scientists need the added benefit of an LC/MS system to produce greater analytical insights,” added Glen Mella, Chief Executive of Axcend.

Liquid chromatography, which is a method of sample separation, commonly uses MS as a detection method in a wide range of markets such as chemicals, pharmaceuticals and environmental analysis.

According to Top Down Analytics, the analytical HPLC-MS market is valued at $ billion today.

The companies’ combined technology supports timely testing and utilises substantially less solvents than the traditional LC and MS systems, resulting in lower running costs and solvent disposal.

“As far as we are aware there is no other LC/MS combination today which provides such a powerful offering in such a small footprint,” added Tracey.

Follow News & Updates from Microsaic Systems here: Microsaic Systems (AIM:MSYS)

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist